Matthew Keller
Stock Analyst at H.C. Wainwright
(0.09)
# 4,402
Out of 4,456 analysts
86
Total ratings
25.4%
Success rate
-19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Keller
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GALT Galectin Therapeutics | Reiterated: Buy | $11 | $4.99 | +120.44% | 10 | Jun 23, 2026 | |
| MCRB Seres Therapeutics | Initiated Coverage: Buy | $12 | $7.06 | +69.97% | 1 | Jun 23, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Downgraded: Hold | n/a | $1.63 | - | 5 | May 20, 2026 | |
| GRI GRI Bio | Reiterated: Buy | $10 | $1.82 | +449.45% | 9 | May 14, 2026 | |
| KYNB Kyntra Bio | Reiterated: Buy | $43 | $7.25 | +493.51% | 13 | May 12, 2026 | |
| IFRX InflaRx | Rated: Buy | $6 → $8 | $1.92 | +316.67% | 10 | May 12, 2026 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $31 | $1.52 | +1,939.47% | 10 | May 12, 2026 | |
| PHIO Phio Pharmaceuticals | Reiterated: Buy | $14 | $0.97 | +1,343.30% | 9 | May 8, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $18 | $6.29 | +186.17% | 10 | May 7, 2026 | |
| ITRMF Iterum Therapeutics plc | Downgraded: Hold | n/a | $0.05 | - | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $22.87 | - | 4 | Oct 30, 2025 |
Galectin Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $11
Current: $4.99
Upside: +120.44%
Seres Therapeutics
Jun 23, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $7.06
Upside: +69.97%
60 Degrees Pharmaceuticals
May 20, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.63
Upside: -
GRI Bio
May 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.82
Upside: +449.45%
Kyntra Bio
May 12, 2026
Reiterated: Buy
Price Target: $43
Current: $7.25
Upside: +493.51%
InflaRx
May 12, 2026
Rated: Buy
Price Target: $6 → $8
Current: $1.92
Upside: +316.67%
Acurx Pharmaceuticals
May 12, 2026
Reiterated: Buy
Price Target: $31
Current: $1.52
Upside: +1,939.47%
Phio Pharmaceuticals
May 8, 2026
Reiterated: Buy
Price Target: $14
Current: $0.97
Upside: +1,343.30%
Gyre Therapeutics
May 7, 2026
Reiterated: Buy
Price Target: $18
Current: $6.29
Upside: +186.17%
Iterum Therapeutics plc
Mar 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.05
Upside: -
Oct 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $22.87
Upside: -